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A central feature of the immune synapse (IS) is the tight compartmentalization of mem-
brane receptors and signaling mediators that is functional for its ability to coordinate 
T cell activation. Second messengers centrally implicated in this process, such as Ca2+ 
and diacyl glycerol, also undergo compartmentalization at the IS. Current evidence 
suggests a more complex scenario for cyclic AMP (cAMP), which acts both as positive 
and as negative regulator of T-cell antigen receptor (TCR) signaling and which, as such, 
must be subjected to a tight spatiotemporal control to allow for signaling at the IS. Here, 
we have used two bacterial adenylate cyclase toxins that produce cAMP at different 
subcellular localizations as the result of their distinct routes of cell invasion, namely 
Bordetella pertussis CyaA and Bacillus anthracis edema toxin (ET), to address the ability 
of the T cell to confine cAMP to the site of production and to address the impact of 
compartmentalized cAMP production on IS assembly and function. We show that CyaA, 
which produces cAMP close to the synaptic membrane, affects IS stability by modulating 
not only the distribution of LFA-1 and its partners talin and L-plastin, as previously partly 
reported but also by promoting the sustained synaptic accumulation of the A-kinase 
adaptor protein ezrin and protein kinase A while suppressing the β-arrestin-mediated 
recruitment of phosphodiesterase 4B. These effects are dependent on the catalytic 
activity of the toxin and can be reproduced by treatment with a non-hydrolyzable cAMP 
analog. Remarkably, none of these effects are elicited by ET, which produces cAMP at a 
perinuclear localization, despite its ability to suppress TCR signaling and T cell activation 
through its cAMP-elevating activity. These results show that the IS responds solely to 
local elevations of cAMP and provide evidence that potent compartmentalization mech-
anisms are operational in T cells to contain cAMP close to the site of production, even 
when produced at supraphysiological levels.
Keywords: immune synapse, cyclic aMP, compartmentalization, T-cell antigen receptor signaling, adenylate 
cyclase toxin
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inTrODUcTiOn
High concentrations of cyclic AMP (cAMP) are known to sup-
press the activation and function of immune cells (1). Several 
bacterial pathogens exploit this property to evade the immune 
response by producing cAMP-elevating toxins, as exemplified 
by the ADP-ribosylating toxins of Vibrio cholerae or Bordetella 
pertussis (PT), which promote the accumulation of cAMP by 
activating cellular Gs proteins or inactivating cellular Gi proteins, 
respectively (2, 3), or the adenylate cyclase (AC) toxins produced 
by Bordetella pertussis (CyaA), Bacillus anthracis [edema toxin 
(ET)], or Pseudomonas aeruginosa (ExoY), which directly cata-
lyze cAMP production in infected cells (4–6).
T lymphocytes are among the cellular targets of bacterial AC 
toxins (7, 8). We have previously reported that both CyaA and 
ET suppress T-cell antigen receptor (TCR) signaling and T cell 
activation and proliferation through their cAMP-elevating activ-
ity (9, 10) and impair T cell migration by inhibiting chemokine 
receptor signaling (9, 11). At low concentrations, they moreover 
instruct CD4 T  cells to differentiate to Th2 and Th17 effectors 
by selectively affecting the activation of specific components of 
the TCR signaling cascade (12, 13). Of note, we have shown that 
CyaA binds to LFA-1, which allows for its accumulation at the 
highly specialized signaling platform that forms at the interface 
of T cells with cognate antigen-presenting cells (APCs), known as 
the immune synapse (IS) (14, 15). Following its internalization, 
CyaA is retained at a subsynaptic localization, catalyzing the pro-
duction of cAMP which suppresses TCR signaling and promotes 
the protein kinase A (PKA)-dependent disengagement of LFA-1 
from the IS, which results in IS disassembly (14).
Compartmentalization of membrane receptors and intracel-
lular signaling molecules in the concentric synaptic subdomains 
of the central, peripheral, and distal supramolecular activation 
clusters (SMAC) is one of the most striking features of the IS, on 
which its function in the orchestration of the signals that drive 
T  cell activation crucially depends (15). Remarkably, compart-
mentalization extends to second messengers that are generated at 
the IS, including Ca2+, diacyl glycerol, and PIP3 (16–19). This is 
achieved through the tight spatiotemporal control of the enzymes 
responsible for their generation as well as for their degradation, as 
exemplified for cAMP (20). TCR engagement results in the tran-
sient accumulation of cAMP (21), which is essential at the initial 
steps of the signaling cascade to promote the EPAC1-dependent 
activation of Rap1 (22), a small GTPase implicated in inside-out 
signaling by the TCR to induce the open, active conformation of 
LFA-1 that is essential to stabilize the IS (23, 24). TCR engage-
ment also promotes the synaptic accumulation of ezrin (25, 26), 
an actin-binding protein and a member of the A-kinase adaptor 
proteins (AKAP) that recruits PKA to the IS, where it can be 
locally activated by cAMP (27). PKA has the ability to negatively 
regulate TCR signaling by enhancing the activity of the kinase 
Csk, which inhibits the initiating kinase Lck (28). However, in 
the presence of costimulation by CD28, which accumulates at the 
cSMAC together with the TCR (15), premature termination of 
TCR signaling is prevented by the local degradation of cAMP 
through the β-arrestin-dependent recruitment of phosphodies-
terase 4B (PDE4B) (29). Moreover PKA is displaced from the 
IS to the opposite pole of the cell (30, 31), allowing signaling to 
proceed for the sustained timeframe required for T cell activation.
Although these findings support the notion that cAMP is pro-
duced and confined close to engaged TCRs to locally modulate 
signaling, a formal proof that T cells are indeed able to limit cAMP 
diffusion from the sites of production within their scant cytoplasm 
such that only the molecules within specific cAMP domains can 
respond is as yet lacking. Here, we have compared the ability of 
T cells to assemble a functional IS, used as a readout of a process 
where signaling is orchestrated within the restricted area of the 
synaptic membrane, following intoxication with B. pertussis 
CyaA or B. anthracis ET. While both these toxins catalyze a robust 
elevation in cAMP, they exploit different mechanisms to enter the 
host cell, leading to the generation of cAMP domains at different 
subcellular localizations. Namely, after binding to its cell target 
CyaA remains associated with the plasma membrane, catalyzing 
the generation of a plasma membrane-proximal cAMP pool. At 
variance, after its receptor-mediated internalization at the plasma 
membrane ET catalyzes the production of cAMP at a perinuclear 
localization, where the toxin is released from late endosomes, 
remaining associated with their cytosolic face (32, 33). We show 
that CyaA impairs IS stability not only by inducing the disen-
gagement of LFA-1 and its partners talin and L-plastin but also 
by promoting the sustained synaptic accumulation of ezrin and 
PKA while suppressing the recruitment of β-arrestin and PDE4B. 
These effects are dependent on the cAMP-elevating activity of 
the toxin and can be reproduced by a non-hydrolyzable cAMP 
analog. Remarkably, none of these effects are elicited by ET, 
despite its ability to suppress TCR signaling and T cell activation 
in a cAMP-dependent fashion, indicating that the IS can only be 
modulated by locally generated cAMP domains and supporting 
the notion that T  cells are able to contain cAMP close to the 
site of production, even within the limited range of their scant 
cytoplasm.
MaTerials anD MeThODs
cells, antibodies, and reagents
Primary T cells were purified from buffy coats from anonymous 
healthy donors using the StemSep Human T cell enrichment kit 
(Voden Medical InstrumentsSpA). Raji B-cells (of human origin) 
were used as APC.
Anti-talin (clone 8d4), anti-ezrin (E1281), and anti-PDE4B 
(sc-25812) antibodies were purchased from Sigma-Aldrich. 
Anti-PDE4B (sc-25812), anti-P-Erk (T202/Y204), and anti-Erk2 
antibodies were purchased from Santa Cruz Biotechnology. Anti-
CD11a (27/CD11a) mAb and PE-labeled anti-CD3, FITC-labeled 
anti-CD69 mAb, and PE-labeled anti-CD25 mAb were purchased 
from BD Biosciences. Anti-β-arrestin-2 (ab54790) mAb was from 
Abcam. Anti-L-Plastin (clone LPL4A.1), PE-labeled phalloidin 
(A34055) and Dynabeads® Human T-Activator CD3/CD28 
were from Thermo-scientific. AlexaFluor 488- and Alexa Fluor 
555-labeled secondary antibodies were from Molecular Probes. 
Anti-phosphotyrosine mAb (clone 4G10) was from Millipore.
SEB and SEE were purchased from Toxin Technology and 
handled in accordance with the specific hazard and safe handling 
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practices. Cell Tracker Blue was purchased from Molecular 
Probes. Poly-l-lysine, 8-CPT-cAMP, and PP2 were purchased 
from Sigma-Aldrich. Carboxyfluorescein succinimidyl ester 
(CFSE) was purchased from Molecular Probes Europe BV 
(Leiden, The Netherlands).
Toxins
CyaA and its enzymatically inactive variant CyaA-E5 (resulting 
from a Leu-Gln dipeptide insertion between D188 and I189 in 
the catalytic core of the enzyme) were expressed in E. coli and 
purified to near homogeneity by previously established proce-
dures modified as described in order to eliminate most of the 
contaminating endotoxin (<0.5 EU/μg protein) (34). The specific 
activity of CyaA, measured as described in Ladant et al. (35) was 
higher than 500 µmol cAMP/min/mg whereas CyaA-E5 had no 
detectable enzymatic activity. PA, EF, and EF-K346R (mEF), an 
AC mutant form of EF with 10,000-fold less catalytic activity (36) 
were expressed in E. coli as N-terminal His-tag fusions in BL21 
DE3 (Novagen Inc.) and purified by Ni-charged Hitrap chelating 
(Amersham Biosciences) as described (32, 37). Adenylyl cyclase 
activity was measured in the presence of 10  mM ATP, 10  µM 
CaM, 1.2 µM free CaCl2, 500 µM BAPTA, and 10 mM MgCl2 as 
described (38). Toxins were handled in accordance with biosafety 
handling practices.
cell intoxication and caMP Measurements
For cAMP and proliferation assays, T cells were intoxicated with 
45 nM CyaA or mCyaA by incubation in serum-free RPMI 1640 
(supplemented with 2  mM CaCl2) at 37°C for 15–30  min. For 
intoxication with ET or mET, the binding-competent toxin was 
first assembled by incubation of the receptor-binding subunit 
protective antigen PA (19  nM) with the cataytic subunit EF 
or its inactive mutant (11 nM) (ratio PA:EF or mEF = 1.6) for 
15–30  min at 37°C. T  cells were then intoxicated with ET or 
mET by incubation in complete medium at 37°C for 2–4  h. 
Under these conditions maximal cAMP levels were reached, as 
previously reported (9, 10, 12). For conjugate experiments, T cells 
were incubated with 45 nM CyaA or mCyaA in serum-free RPMI 
1640 (supplemented with 2 mM CaCl2) on ice for 15 min to allow 
binding, then washed, resuspended in phosphate-buffered saline 
(PBS), mixed with APCs (1:1), and shifted to 37°C as described 
(14). Alternatively, T cells were intoxicated with ET/mET for 4 h 
as described above, then washed, resuspended in PBS, mixed with 
APCs (1:1), and shifted to 37°C.
Intracellular cAMP was quantified by enzyme-linked immu-
noassay (Biotrak EIA; Amersham Biosciences) according to the 
manufacturers’ instructions. For these experiments, 2 × 106 cells 
T cells were plated in 96-well plates in 200 µl RPMI 1640-7.5% 
FCS and treated with CyaA/mCyaA or ET/mET as described 
above. At the end of the treatment, cells were washed 2× in PBS 
and lysed in the lysis reagent included in the kit.
conjugate Formation and confocal 
Microscopy
Conjugate formation was carried out as described (39). Briefly, 
Raji cells (used as APC) were pulsed for 2 h with 10 µg/ml SEE/
SEB and labeled with 10 µM Cell Tracker Blue for the last 20 min. 
They were then washed, mixed with T cells (1:1), either untreated 
or intoxicated as described above, incubated at 37°C for 15 min 
and plated on polylysine-coated wells of diagnostic microscope 
slides (Erie Scientific Company). Alternatively, 100 µM of 8-CPT 
was added 2  min after the start of conjugate formation. Cells 
were allowed to adhere for 15 min and then fixed in methanol 
at −20°C for 10 min or in 4% paraformaldehyde for 20 min at 
RT. Antigen-independent conjugates were obtained by mixing 
T  cells and APC in the absence of SEE/SEB. Representative 
images of the latter after staining with the mAbs used are shown 
in Figure S1 in Supplementary Material. Where required due to 
a strong antibody signal at the APC side of the IS, 8 × 104 T cells 
were resuspended in 30 µl medium, added with 2 µl of washed 
Dynabeads® Human T-Activator CD3/CD28 to obtain a bead-
to-cell ratio of 1:1 according to the manufacturer’s instructions, 
incubated at 37°C for 15  min and plated on polylysine-coated 
wells as above.
After fixation, samples were processed for immunofluores-
cence as previously described (39). Confocal microscopy was 
performed on a LSM700 (Carl Zeiss, Inc.) using a 63× objective. 
Z series of optical sections were performed at 0.5-µm increments. 
Images to quantify were acquired with pinholes opened to obtain 
0.8-μm-thick sections. Detectors were set to detect an optimal 
signal below the saturation limits. Images were processed with 
Zen 2009 image software (Carl Zeiss, Inc.).
Scoring of conjugates for the polarization of the molecule of 
interest the IS was based on the presence of staining selectively 
concentrated at the T-cell contact with the APC compared to the 
remaining T cell area. Clustering of molecules at the T-cell/APC 
contact site was quantified on median optical confocal sections 
using ImageJ software (National Institutes of Health). Namely, 
fluorescence intensity of the molecule at the IS area was divided 
by the intensity calculated for the entire cell and is expressed 
as relative recruitment index as previously described (39). The 
quantitative colocalization analysis was performed on median 
optical sections using ImageJ and JACoP plug-in to determine 
Manders’ coefficient.
T cell activation and Proliferation assays, 
immunoblots
Proliferation was measured by flow cytometry using the CFSE 
dilution method. Briefly, T cells were resuspended at 20 × 106/ml 
in PBS and stained with 10 µM CFSE for 8 min at RT. Cells were 
subsequently washed twice in RPMI-7.5% fetal calf serum, resus-
pended at a concentration of 5 × 106/ml and either left untreated 
or intoxicated with CyaA, ET, or the respective mutants, or treated 
with 8-CPT, as described above. Raji cells were pulsed for 2 h with 
10 µg/ml SEE/SEB, fixed with 0.05% glutaraldehyde PBS for 30 s, 
added with 0.2 M glycine in PBS to block the reaction, washed 
twice with PBS-1% BCS and resuspended in RPMI-7.5% FCS at a 
concentration of 5 × 106/ml. T cells and Raji cells were then mixed 
in 12-well plates at a ratio of 1:1, incubated at 37°C for 24–120 
and analyzed by flow cytometry after gating on lymphocytes and 
counterstaining with PE-labeled anti-CD3 mAb. T cell activation 
was assessed by flow cytometric analysis of the activation markers 
CD69 and CD25 on cells either left untreated or intoxicated with 
CyaA, ET or the respective mutants, or treated with 8-CPT, and 
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activated with SAg-pulsed fixed Raji cells for 16–24  h. For the 
immunoblot analysis of Erk activation T cells were intoxicated 
and activated as detailed above for 15 min. Post-nuclear superna-
tants were processed for immunoblot as described (11).
statistical analyses
Mean values, SD values, and Student’s t test (unpaired) were cal-
culated using the Microsoft Excel application. One-way ANOVA 
followed by Tukey post hoc test was used for multiple comparisons 
and calculated using GraphPad (Prism Software). A P value <0.05 
was considered as statistically significant.
resUlTs
lFa-1 accumulation at the is is 
compromised in T cells intoxicated  
With cyaa, but not With eT
To address the susceptibility of the IS to cAMP pools generated 
at different subcellular localizations, peripheral T cells purified 
from healthy donors were first intoxicated with CyaA or ET. Since 
we had previously shown that the kinetics of cAMP production 
by CyaA in T cells is faster compared to ET (9, 12), cells were 
intoxicated with CyaA or ET for 30 min and 2 h, respectively, to 
reach the peak of cAMP production. Under these conditions, high 
levels of cAMP were measurable in both CyaA- and ET-treated 
T  cells (Figure S2A in Supplementary Material). Consistent 
with our previous report, T cell proliferation was suppressed by 
both toxins, as assessed by flow cytometric analysis of CyaA or 
ET-intoxicated T cells loaded with CFSE and mixed with Raji cells, 
used as APC, pulsed with a mix of staphylococcal enterotoxins B 
and E (SEB + SEE; SAg) which together activate a major propor-
tion of the human TCR Vβ repertoire (Figure 1A). In addition, 
T cell activation was inhibited by both toxins, as assessed by flow 
cytometric analysis of the activation markers CD69 and CD25 
(Figures  1B,C), indicating that the cAMP produced by the 
toxins interferes with T cell activation upstream of the autocrine 
IL-2/IL-2 receptor loop on which their proliferation depends. 
Moreover, immunoblot analysis showed that both toxins were 
able to inhibit the activation of Erk, a downstream component 
of the TCR signaling cascade (Figure S2B in Supplementary 
Material).
To compare the impact of cAMP production by CyaA and 
ET on LFA-1 accumulation at the IS, conjugates of CyaA- or 
ET-intoxicated T  cells and SAg-loaded APCs were imaged by 
confocal microscopy following staining with anti-LFA-1 mAb. 
As previously reported, under these conditions LFA-1 was found 
to be distributed evenly along the plasma membrane in CyaA-
treated T cells, at variance with the tight synaptic accumulation 
in non-intoxicated T cells (Figure 2). This effect, which we had 
previously shown to result from disengagement from the IS of 
LFA-1 that had initially accumulated at this location (14), was 
dependent on the cAMP-elevating activity of CyaA, as it was 
not reproduced by the catalytically defective CyaA-E5 mutant 
(mCyaA) (Figure  2). Strikingly, ET did not affect the synaptic 
accumulation of LFA-1 (Figure  2), despite the fact that cAMP 
accumulation in ET-intoxicated T  cells was higher than in the 
same cells intoxicated with CyaA (Figure S2 in Supplementary 
Material). Interestingly, treatment of conjugates with the non-
hydrolyzable cAMP analog, 8-CPT, which diffuses freely through 
the cell, reproduced the effects of CyaA (Figure  2), suggesting 
that signaling modules that control IS architecture are differen-
tially affected by cAMP. Collectively, these results indicate that 
LFA-1 engagement at the IS is exquisitely susceptible to local 
cAMP and that diffusion to the IS of cAMP generated by ET at 
perinuclear late endosomes is prevented notwithstanding its high 
intracellular concentration.
The synaptic accumulation of the lFa-1 
interactors, Talin, and l-Plastin, is 
compromised in T cells intoxicated With 
cyaa, but not With eT
Signaling by TCRs that assemble into microclusters at the dSMAC 
promotes the polymerization of new actin filaments that assist the 
movement of engaged TCRs toward the center of the IS. While 
TCRs eventually concentrate at the cSMAC, F-actin accumulates 
at the pSMAC, stabilizing the T cell-APC conjugate by interacting 
with LFA-1 through the actin adaptor talin (40,  41). The Ca2+-
calmodulin-dependent actin-bundling protein L-plastin is also 
recruited to the pSMAC, where it promotes the sustained accumula-
tion of LFA-1 and talin, further contributing to IS stability (42, 43).
Consistent with our previous report (14), the synaptic accu-
mulation of talin was found to be impaired in T cells intoxicated 
with CyaA (Figure  3A). This effect was reproduced by 8-CPT 
but not by mCyaA (Figure 3A). At variance, talin was found to 
accumulate normally at the IS formed by ET-intoxicated T cells 
(Figure 3A). Similar results were obtained when the distribution 
of L-plastin was analyzed in SAg-specific conjugates of CyaA 
or ET-intoxicated T  cells (Figure  3B). Together, these findings 
provide evidence that cAMP compromises the synaptic accumu-
lation of LFA-1 and its interactors talin and L-plastin only when 
produced from a plasma membrane-proximal localization. Of 
note, while F-actin accumulation at the IS was affected by neither 
CyaA, as previously reported (14), nor EF, it was impaired in the 
presence of 8-CPT (Figure  3C; Figure S4A in Supplementary 
Material). The fact that a robust accumulation of F-actin at the 
APC was observed in SAg-specific conjugates prior to 8-CPT 
addition (Figure S3A in Supplementary Material) indicates that 
under these conditions 8-CPT promotes the dissipation of synap-
tic F-actin, suggesting that the diffuse distribution of this cAMP 
analog could result in the modulation of signaling mediators that 
control F-actin stability, as reported for other cell types (44, 45).
Phosphotyrosine signaling at the is is 
impaired in T cells intoxicated With cyaa, 
but not With eT
Immune synapse destabilization has been associated with a failure 
of T cells to undergo activation and proliferation as the result of 
impaired sustained TCR signaling (46). To understand whether 
the alterations in the accumulation of LFA-1 and its molecular 
partners at the IS resulted in defective TCR signaling, the synaptic 
accumulation of tyrosine phosphoproteins was imaged using an 
FigUre 1 | Continued
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FigUre 1 | CyaA and edema toxin (ET) suppress T cell activation and proliferation. (a) Top, flow cytometric analysis of carboxyfluorescein succinimidyl ester 
(CFSE)-labeled peripheral blood mononuclear cells stimulated for 48, 72, 96, or 120 h with glutaraldehyde-fixed SAg-pulsed antigen-presenting cell (APC). Cells 
were incubated for 15 min on ice with 45 nM of either CyaA or mCyaA, or for 4 h at 37°C with ET (19 nM PA + 11 nM EF) or mET (19 nM PA + 11 nM mEF) before 
washing and mixing with the APCs. Alternatively, 100 µM 8-CPT was added 2 min after cells were mixed with APCs. Cells were labeled with anti-CD3 mAb to 
identify T cells. The histograms show the percentage of T cells having undergone proliferation (CD3+CFSElow) in one of the two donors analyzed. Middle, FACS 
profiles of the same samples at the 96 h time point. Bottom, histograms showing the percentage of T cells having undergone proliferation (CD3+CFSElow) at the 96 h 
time point in the two donors analyzed (mean ± SD). (B,c) Flow cytometric analysis of purified peripheral blood T cells stimulated for 16 h (CD69) or 24 h (CD25) with 
glutaraldehyde-fixed SAg-pulsed APC in the presence or absence of 45 nM CyaA/mCyaA or 11 nM ET/mET or 100 µM 8-CPT as described in (a). Cells were 
labeled with either anti-CD69 (top) or anti CD25 (bottom) mAbs. FACS profiles of a representative donor are shown in (B). The histograms (c) show the percentage 
of CD69+ (left) or CD25+ (right) T cells (mean ± SD, three donors; Student’s t test).
FigUre 2 | Continued
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FigUre 2 | LFA-1 accumulation at the immune synapse (IS) is compromised in T cells intoxicated with CyaA, but not with edema toxin (ET). Immunofluorescence 
analysis of LFA-1 (anti-CD11a mAb) in conjugates of peripheral T cells and SAg-pulsed antigen-presenting cell (APC), incubated at 37°C for 15 min and allowed to 
adhere on polylysine-coated wells for further 15 min. For intoxication, T cells were incubated for 15 min on ice with 45 nM of either CyaA or mCyaA, or for 4 h at 37°C 
with ET (19 nM PA + 11 nM EF) or mET (19 nM PA + 11 nM mEF) before washing and mixing with the APC. Ctrl cells were left untreated. Alternatively, 100 µM 8-CPT 
was added 2 min after T cells were mixed with APCs. Histograms show the percentage of conjugates harboring CD11a at the IS (mean ± SD, n = 3 donors; left) and 
the relative CD11a fluorescence at the T-cell:APC contact site compared with the remaining T cell area (expressed as relative recruitment index; right) (n = 45 cells, 15 
conjugates/donor). Due to the different efficiency of conjugate formation among donors, the percentages of synapses positive for CD11a in treated vs untreated cells 
in each experiment have been normalized taking the value of untreated controls as 100%. The range of CD11a+ synapses in untreated controls from the three donors 
is ~50–90%. Representative images are shown. Size bar, 5 µm. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001. Error bars, SD (one-way ANOVA).
FigUre 3 | Continued
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FigUre 3 | The synaptic accumulation of the LFA-1 interactors, talin, and L-plastin, is compromised in T cells intoxicated with CyaA, but not with edema toxin (ET). 
Immunofluorescence analysis of talin (a), L-plastin (B), or F-actin (phalloidin staining) (c) in conjugates of peripheral T cells and SAg-pulsed antigen-presenting cell 
(APC), incubated at 37°C for 15 min and allowed to adhere on polylysine-coated wells for further 15 min. For intoxication, T cells were incubated for 15 min on ice 
with 45 nM of either CyaA or mCyaA, or for 4 h with ET (19 nM PA + 11 nM EF) or mET (19 nM PA + 11 nM mEF) before washing and mixing with the APC. Ctrl 
cells were left untreated. Alternatively, 100 µM 8-CPT was added 2 min after T cells were mixed with APCs. Histograms show the percentage of conjugates 
harboring talin, L-plastin, or F-actin at the immune synapse (IS) (mean ± SD, n = 3 donors; left), and the relative talin, L-plastin, or F-actin fluorescence at the 
T-cell:APC contact site compared with the remaining T cell area (expressed as relative recruitment index; right) (n = 45 cells, 15 conjugates/donor). Due to the 
different efficiency of conjugate formation among donors, the percentages of synapses positive for each marker in treated vs untreated cells in each experiment have 
been normalized taking the value of untreated controls as 100%. The range of talin-, L-plastin-, and F-actin-positive synapses in untreated controls from the three 
donors is ~70–80%, 40–60%, and 50–70%, respectively. Representative images are shown. Size bar, 5 µm. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001. 
Error bars, SD (one-way ANOVA).
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anti-phosphotyrosine antibody. A weak and diffuse PTyr signal 
was detected in CyaA-intoxicated or 8-CPT-treated T cell conju-
gates, as opposed to the strong and defined signal detected at the 
IS in SAg-specific conjugates of untreated T cells or T cells intoxi-
cated with mCyaA, ET or mET (Figure 4A). Of note, the synaptic 
accumulation of the TCR was not affected by CyaA (Figure 4B), 
ruling out a defect of TCR recruitment to the IS as the cause of the 
impairment in phosphotyrosine signaling in CyaA-intoxicated 
T cells. At variance, 8-CPT treatment resulted in a failure of the 
TCR to remain associated with the IS despite its accumulation 
prior to 8-CPT addition (Figure S3B in Supplementary Material), 
as well as in premature termination of phosphotyrosine signaling 
(Figures S3C and S4B in Supplementary Material). These results 
suggest that by diffusing throughout the cell this cAMP analog 
may modulate mediators of TCR signaling and/or trafficking 
that are not in the normal range of the cAMP-enriched domain 
generated by CyaA at the IS.
The ezrin-Mediated recruitment of PKa to 
the is is enhanced in T cells intoxicated 
With cyaa
Having established that the IS is susceptible to CyaA but not to 
ET, we next investigated the impact of the IS-proximal production 
of cAMP by CyaA on the recruitment of inhibitory cAMP effec-
tors, focusing on PKA type I (PKA-I), which interacts with the 
membrane-microfilament linker and AKAP, ezrin (27). Ezrin 
transiently accumulates at the IS, recruiting PKA to this location 
(25–27), but eventually moves toward the opposite side of the 
cell to the distal pole complex which includes inhibitory proteins 
such as CD43 and PKA (31, 47), allowing the TCR to signal at 
the IS.
Due to the elevated expression of ezrin and PKA-I in Raji cells, 
which made it difficult to unambiguously track this molecule at 
the T cell side of the IS, T cells were conjugated with beads coated 
with anti-CD3 and anti-CD28 antibodies to form surrogate syn-
apses. Confocal imaging of control conjugates showed a largely 
IS-distal localization of both ezrin and PKA-I, consistent with 
the strong synaptic accumulation of tyrosine phosphoproteins. 
Strikingly, ezrin (Figure 5A) and PKA-I (Figure 5B) were found 
associated with the IS in CyaA-intoxicated T cells, accounting for 
their defect in phosphotyrosine signaling. Similar results were 
obtained when T cells were treated with 8-CPT (Figures 5A,B). 
These effects were not reproduced by the AC-defective CyaA 
mutant (Figures  5A,B), indicating that they were mediated by 
cAMP. Hence phosphotyrosine signaling at the IS is dampened 
by the sustained presence of PKA-I, which can be activated by 
the local accumulation of cAMP elicited by CyaA. Interestingly, 
FigUre 4 | Continued
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FigUre 4 | Phosphotyrosine signaling at the immune synapse (IS) is impaired in T cells intoxicated with CyaA, but not with edema toxin (ET). Immunofluorescence 
analysis of PTyr (a) or CD3ζ (B) in conjugates of peripheral T cells and SAg-pulsed antigen-presenting cell (APC), incubated at 37°C for 15 min and allowed to 
adhere on polylysine-coated wells for further 15 min. For intoxication, T cells were incubated for 15 min on ice with 45 nM of either CyaA or mCyaA, or for 4 h with 
ET (19 nM PA + 11 nM EF) or mET (19 nM PA + 11 nM mEF) before washing and mixing with the APC. Ctrl cells were left untreated. Alternatively, 100 µM 8-CPT 
was added 2 min after T cells were mixed with APCs. Histograms show the percentage of conjugates harboring PTyr or CD3ζ at the IS (mean ± SD, n = 3 donors; 
left) and the relative PTyr or CD3ζ fluorescence at the T-cell:APC contact site compared with the remaining T cell area (expressed as relative recruitment index; right) 
(n = 45 conjugates, 15 cells/donor). Due to the different efficiency of conjugate formation among donors, the percentages of synapses positive for each marker in 
treated vs untreated cells in each experiment have been normalized taking the value of untreated controls as 100%. The range of PTyr- and CD3ζ-positive synapses 
in untreated controls from the three donors is ~87–98 and 60–80%, respectively. Representative images are shown. Size bar, 5 µm. *P < 0.05; **P < 0.01; 
***P < 0.005; ****P < 0.001. Error bars, SD (one-way ANOVA).
FigUre 5 | The ezrin-mediated recruitment of protein kinase A (PKA) to the immune synapse (IS) is enhanced in T cells intoxicated with CyaA.  
(a,B) Immunofluorescence analysis of ezrin (a) or PKA-I (B) in peripheral T cells incubated at 37°C for 15 min with beads coated with anti-CD3 and anti-CD28 
mAbs and allowed to adhere on polylysine-coated wells for further 15 min. For intoxication T cells were incubated for 15 min on ice with 45 nM of either CyaA or 
mCyaA before washing and mixing with the beads. Ctrl cells were left untreated. Alternatively, 100 µM 8-CPT was added 2 min after T cells were mixed with the 
beads. Histograms show the percentage of conjugates harboring ezrin or PKA-I at the T cell-bead contact (mean ± SD, n = 3 donors; left) and the relative ezrin or 
PKA-I fluorescence at the T cell-bead contact compared with the remaining T cell area (expressed as relative recruitment index; right) (n = 45 cells, 15 cells/donor). 
Representative images are shown. Size bar, 5 µm. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001. Error bars, SD (one-way ANOVA).
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these data also provide evidence that the synaptic accumulation 
of ezrin is positively regulated by cAMP.
The β-arrestin-Mediated recruitment of 
PDe4B at the is is impaired in T cells 
intoxicated With cyaa
In addition to the ezrin-dependent relocalization of PKA at the 
distal pole away from the IS, T cells exploit an additional strategy 
to limit signaling at the IS. Namely, TCR coengagement with the 
costimulatory receptor CD28 has been reported to elicit the local 
degradation of cAMP by promoting the lipid raft recruitment and 
synaptic accumulation of the phosphodiesterase PDE4B through 
its constitutive interaction with β-arrestin (29).
The impact of CyaA intoxication on the IS recruitment of 
β-arrestin and PDE4B was addressed by imaging conjugates of 
CyaA-intoxicated T cells with SAg-pulsed APCs (β-arrestin) or 
beads coated with anti-CD3 and anti-CD28 mAbs. At variance 
with control conjugates, which showed a strong accumulation of 
both β-arrestin (Figure 6A) and PDE4B (Figure 6B) at the IS, 
CyaA-treated cells showed a diffuse distribution of either mol-
ecule (Figures 6A,B). These effects were reproduced by 8-CPT 
but not by mCyaA (Figures  6A,B). Colocalization analyses 
showed moreover a strong synaptic colocalization of β-arrestin 
and PDE4B (Figure  6C). Consistent with their constitutive 
interaction (29), this colocalization was maintained after their 
dissipation away from the IS in CyaA-treated T cells (Figure 6C). 
These results indicate that cAMP activates a regulatory loop that 
FigUre 6 | The β-arrestin-mediated recruitment of PDE4B at the immune synapse (IS) is impaired in T cells intoxicated with CyaA. Immunofluorescence analysis 
of β-arrestin (a) or PDE4B (B) in conjugates of peripheral T cells and SAg-pulsed antigen-presenting cell (APC) (a) or beads coated with anti-CD3 and anti-CD28 
mAbs (B), incubated at 37°C for 15 min and allowed to adhere on polylysine-coated wells for further 15 min. For intoxication T cells were incubated for 15 min 
on ice with 45 nM of either CyaA or mCyaA before washing and mixing with the APC. Ctrl cells were left untreated. Alternatively, 100 µM 8-CPT was added 2 min 
after T cells were mixed with APCs. Histograms show the percentage of conjugates harboring β-arrestin or PDE4B at the IS (mean ± SD, n = 3 donors; left) and 
the relative β-arrestin or PDE4B fluorescence at the T-cell:APC/bead contact site compared with the remaining T cell area (expressed as relative recruitment 
index; right) (n = 45 cells, 15 cells/donor). Due to the different efficiency of conjugate formation among donors, the percentages of synapses positive for each 
marker in treated vs untreated cells in each experiment have been normalized taking the value of untreated controls as 100%. The range of β-arrestin- and 
PDE4B-positive synapses in untreated controls from the three donors is ~30 and ~60%, respectively. (c) Colocalization analysis of β-arrestin and PDE4B in 
peripheral T cells incubated at 37°C for 15 min with beads coated with anti-CD3 and anti-CD28 mAbs (CD3 + 28) and allowed to adhere on polylysine-coated 
wells for further 15 min. For intoxication, T cells were incubated for 15 min on ice with 45 nM of CyaA before washing and mixing with the beads. Alternatively, 
20 µM PP2 was added 2 min after T cells were mixed with the beads. Ctrl cells were treated with carrier. A sample of ctr cells was incubated at 37°C for 15 min 
without beads for the colocalization analysis of PDE4B and β-arrestin in resting cells (no act). Histograms show (left) the percentage of conjugates harboring both 
PDE4B and β-arrestin at the IS (mean ± SD, n = 3 donors) or (right) the colocalization of PDE4B and β-arrestin, quantified and expressed as Mander’s coefficient 
(mean ± SD, one-way ANOVA; n = 30 cells, 10 cells/donor, 3 donors). The percentages of synapses positive for each marker in treated vs untreated cells in 
each experiment have been normalized taking the value of untreated controls as 100%. The range of synapses positive for both PDE4B and β-arrestin in 
untreated controls from the three donors is ~50–60%. Representative images are shown. Size bar, 5 µm. *P < 0.05; **P < 0.01; ***P < 0.005; ****P < 0.001. 
Error bars, SD.
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displaces PDE4B and β-arrestin from the IS, thereby preventing 
cAMP degradation and thus suppressing TCR signaling.
To understand whether the abnormalities in distribution of 
the β-arrestin/PDE4B complex in CyaA-intoxicated T cells could 
be the consequence of premature termination of TCR signaling 
by cAMP/PKA through the Csk-mediated inhibition of the initi-
ating kinase Lck (30), we imaged β-arrestin and PDE4B in T cells 
conjugated with beads coated with anti-CD3 and anti-CD28 
mAbs and treated with the Src kinase inhibitor PP2 shortly after 
conjugate formation to allow for IS assembly (as assessed by stain-
ing with anti-PTyr mAb; Figure S5 in Supplementary Material). 
Under these conditions β-arrestin and PDE4B were found to 
dissipate together away from the IS, similar to CyaA-treated 
T cells (Figure 6C), supporting the notion that CyaA promotes 
the redistribution of the PDE4B-β-arrestin complex through its 
ability to inhibit Lck, thereby shutting off TCR signaling.
DiscUssiOn
Using two bacterial AC toxins that catalyze the production of 
cAMP at different subcellular localizations as the result of their 
different routes for delivery into host cells, namely B. pertussis 
CyaA and B. anthracis ET (32, 33), here, we have addressed the 
outcome of cAMP compartmentalization on IS stability and 
function. We show that the IS is exquisitely susceptible to local 
cAMP domains and provide evidence that potent mechanisms for 
preventing cAMP diffusion away from the site of production are 
operational in T cells. We moreover characterize the mechanisms 
through which cAMP affects the architecture and function of the 
IS, identifying the pSMAC as a selective target of the suppressive 
effects of cAMP.
We had previously reported that CyaA exploits its ability to 
bind LFA-1 during IS assembly to concentrate at the pSMAC, 
wherefrom it is internalized into a subsynaptic compartment (14). 
This localization is ideally suited for the generation of a cAMP 
pool close to the IS membrane, where it can modulate signaling 
through PKA and other effectors. The ability of CyaA to promote 
the premature disengagement of LFA-1 from the IS (14) is likely 
the consequence of impaired signaling by the TCR, on which the 
conformational change required for talin binding depends (48, 49), 
resulting in talin dissipation and its uncoupling from the underly-
ing actin cytoskeleton. Consistent with this notion, we found that 
phosphotyrosine signaling is severely impaired at the IS of CyaA-
intoxicated T cells, notwithstanding the fact that the accumulation 
of the TCR at the IS is not affected by the toxin. Interestingly, a 
similar differential effect on LFA-1 and TCR clustering at the IS 
has been observed in T cells knocked down for L-plastin expres-
sion (42), suggesting that LFA-1 might dissipate faster from the IS 
compared to the TCR when signaling is turned off. Alternatively, 
the mechanism that controls the polarized transport of endosomal 
TCRs to the IS to replace internalized TCRs (50), that is expected 
to be triggered by microcluster-associated TCRs at the dSMAC, 
may be affected to a lesser extent due to compartmentalization of 
cAMP close to the site of production by CyaA, such that cAMP 
is prevented to reach the dSMAC. The fact that 8-CPT impairs 
sustained TCR clustering at the IS supports this notion. Indeed, 
as a membrane-permeable and diffusible non-hydrolyzable cAMP 
analog that is maintained at high concentrations throughout the 
cell, it has the potential to activate cAMP effectors at any subcel-
lular localization, including the dSMAC. Together with premature 
depolymerization of synaptic F-actin, this may account for the 
impairment in F-actin accumulation at the IS observed in the 
presence of 8-CPT, but not of CyaA, since new actin filaments, on 
which the transport of TCR microclusters to the cSMAC depends, 
are polymerized at the dSMAC. Yet, we cannot rule out that in 
our experimental setting the synaptic concentration of 8-CPT may 
be higher than the cAMP concentration locally accumulated by 
CyaA, thereby accounting for the more profound effects of 8-CPT.
Although several steps of the TCR signaling cascade are potential 
targets of PKA, this kinase has been implicated in the initial step 
of TCR signaling, namely phosphorylation of the ITAMs within 
the CD3ζ subunit of the TCR complex by the kinase Lck (51). 
This is achieved through the PKA-I-mediated phosphorylation 
and resulting activation of the kinase Csk, which phosphorylates 
Lck on an inhibitory residue, thereby preventing TCR signaling 
(28). PKA-I undergoes a dynamic relocalization during IS assem-
bly, being initially recruited by ezrin which is also responsible 
for its subsequent displacement away from the IS to the distant 
pole complex (27, 30). Our results showing that ezrin and PKA-I 
co-accumulate at the IS of CyaA-intoxicated T cells, at variance 
with control conjugates where they are found at the distal T cell 
pole, are consistent with the AKAP function of ezrin and indicate 
that this function allows for PKA to be recruited to the cAMP-
enriched domain generated by CyaA at the IS, in a localization 
where TCR signaling can be modulated. Interestingly, they also 
provide evidence that the synaptic localization of ezrin can be sta-
bilized by cAMP. Ezrin has been shown to be phosphorylated by 
PKA on a specific serine residue in gastric parietal cells (52). This 
event is critical for its participation in multimolecular complexes 
that provide spatial cues for H,K-ATPase trafficking and regulated 
HCl secretion (53). Phosphorylated ezrin restores moreover actin 
organization and PKA submembrane compartmentalization in 
cystic fibrosis airway cells, which corrects the chloride secretion 
defect observed in the presence of the trafficking-incompetent 
F508del mutant of the cystic fibrosis transmembrane regulator 
(54). This suggests that a feedback loop might be operational at 
the IS in the presence of cAMP, whereby PKA recruitment by 
ezrin, which associates with the pSMAC, would result in ezrin 
phosphorylation by PKA, reinforcing its interactions with synap-
tic molecular partners, such as the transmembrane adaptor PAG, 
ezrin binding protein 50 and Csk binding protein (55).
PDEs are central to the generation of cAMP domains, as 
elegantly demonstrated in cardiomyocytes and neurons, where 
they are recruited to the relevant subcellular localization by 
AKAPs in concert with β-arrestin (56). A similar mechanism 
has been identified in T cells, where TCR signaling promotes an 
elevation in cAMP which in the presence of CD28 costimulation 
is rapidly degraded by PDE4B, the latter forming a constitutive 
complex with β-arrestin at lipid rafts that is recruited to the IS 
(29). We found that CyaA not only catalyzes the local production 
of cAMP but also prevents its degradation by suppressing the 
β-arrestin-mediated recruitment of PDE4B at the IS, thereby 
allowing for robust and sustained PKA signaling. The defect 
in phosphotyrosine signaling observed in CyaA-intoxicated 
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